Home prices cooled in July at the fastest rate in the history of S&P Case-Shiller Index

Home prices cooled in July at the fastest rate in the history of S&P Case-Shiller Index


A ‘for sale’ sign is displayed outside a single family home on September 22, 2022 in Los Angeles, California.

Allison Dinner | Getty Images

U.S. home prices cooled in July at the fastest rate in the history of the S&P CoreLogic Case-Shiller Index, according to a report released Tuesday.

Home prices in July were still higher than they were a year ago, but cooled significantly from June gains. Prices nationally rose 15.8% over July 2021, well below the 18.1% increase in the previous month, according to the report.

The 10-City composite, which tracks prices in major metropolitan areas such as New York and Boston, climbed 14.9% year over year, down from 17.4% in June. The 20-City composite, which adds regions such as the Seattle metro area and greater Detroit, gained 16.1%, down from 18.7% in the previous month. July’s year-over-year gains were lower compared with June in each of the cities covered by the index.

30-year fixed-rate mortgage jumps over 7 percent

“July’s report reflects a forceful deceleration,” wrote Craig J. Lazzara, managing director at S&P DJI in a release, noting the difference in the annual gains in June and July. The 2.3 percentage point “difference between those two monthly rates of gain is the largest deceleration in the history of the index.”

Tampa, Florida, Miami and Dallas saw the highest annual gains among the 20 cities in July, with increases of 31.8%, 31.7% and 24.7%, respectively. Washington, D.C., Minneapolis and San Francisco saw the smallest gains, but were still well above year-ago levels.

Another recent report from the National Association of Realtors showed home prices softening dramatically from June to July. Prices usually fall during that time, due to the strong seasonality of the housing market, but the decline was three times the average decline historically.

The share of homes with price cuts reached about 20% in August, the same as in 2017, according to Realtor.com.

“For homeowners planning to list, today’s market is significantly different than the one from even 3 weeks ago,” said George Ratiu, senior economist and manager of economic research at Realtor.com.

Home prices are dropping because affordability has weakened dramatically due to fast-rising mortgage rates. The average rate on the popular 30-year fixed mortgage started this year around 3%, but by June had briefly surpassed 6%. It remained in the high 5% range throughout July and is now edging toward 7%, making the average monthly payment about 70% higher than it was a year ago.

“As the Federal Reserve continues to move interest rates upward, mortgage financing has become more expensive, a process that continues to this day. Given the prospects for a more challenging macroeconomic environment, home prices may well continue to decelerate,” Lazzara said.



Source

Spotify teams up with Peloton to launch global fitness content hub
Business

Spotify teams up with Peloton to launch global fitness content hub

Spotify is increasing its push beyond music and podcasts as the company on Monday announced a new fitness category partnership with Peloton Interactive. The deal will make more than 1,400 Peloton classes available to Spotify Premium subscribers across most of its global markets, embedding fitness content directly into Spotify’s existing audio and video ecosystem, according […]

Read More
Wall Street expects solid Q1 results for GM, as Ford and Stellantis try to gain traction
Business

Wall Street expects solid Q1 results for GM, as Ford and Stellantis try to gain traction

Traders work on the floor at the New York Stock Exchange in New York City, March 27, 2025. Brendan McDermid | Reuters DETROIT — As America’s largest automakers prepare to report first-quarter earnings results this week amid rising oil and commodity costs due to the Iran war, they find themselves traversing different terrains. General Motors […]

Read More
Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial
Business

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, USA. Spencer Grant | Universal Images Group | Getty Images Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition met its goals in a late-stage trial, marking a milestone for the field of gene editing and putting the company on track to seek approval […]

Read More